The Effect of Trigger Point Injections on Pain in Patients with Advanced Cancer
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: It has been reported that in 62.5% of cases of incurable cancer pain, the complaint is due to myofascial pain syndrome. Trigger point injections using dibucaine hydrochloride help patients with such cancer pain. This study evaluated the efficacy of trigger point injections for alleviating pain in patients with advanced cancer. Methods: Twenty patients with advanced cancer who had a life expectancy of 6 months or less and had been diagnosed with myofascial pain syndrome were treated with trigger point injections. Prior to treatment, a Visual Analog Scale (VAS) was used to measure the resting pain level and discomfort upon application of pressure on the site of pain. These values were compared with last treatment measurements. Results: The mean pre-treatment VAS scores for pain at rest and upon application of pressure on the pain site were 7.3 and 9.0, respectively. These scores decreased significantly to 1.95 and 3.2, respectively, after the treatment (P<0.05). Conclusion: Trigger point injection is an alternative and effective pain control modality for advanced cancer patients with myofascial pain syndrome.
Abstract
Background: It has been reported that in 62.5% of cases of incurable cancer pain, the complaint is due to myofascial pain syndrome. Trigger point injections using dibucaine hydrochloride help patients with such cancer pain. This study evaluated the efficacy of trigger point injections for alleviating pain in patients with advanced cancer. Methods: Twenty patients with advanced cancer who had a life expectancy of 6 months or less and had been diagnosed with myofascial pain syndrome were treated with trigger point injections. Prior to treatment, a Visual Analog Scale (VAS) was used to measure the resting pain level and discomfort upon application of pressure on the site of pain. These values were compared with last treatment measurements. Results: The mean pre-treatment VAS scores for pain at rest and upon application of pressure on the pain site were 7.3 and 9.0, respectively. These scores decreased significantly to 1.95 and 3.2, respectively, after the treatment (P<0.05). Conclusion: Trigger point injection is an alternative and effective pain control modality for advanced cancer patients with myofascial pain syndrome.
참고문헌 (13)
- Kim CH, "Trigger point injection for myofascial pain syndrome", J Korean Orthop Ultrasound Soc, 7(Suppl 2), pp.127~131 (2014)
- Scott NA, "Trigger point injections for chronic non-malignant musculoskeletal pain : a systematic review", Pain Med, 10, pp.54~69 (2009)
- Twycross RG, "Pain in far-advanced cancer", Pain, 14, pp.303~310 (1982)
- Cardoso LR, "Myofascial pain syndrome after head and neck cancer treatment : Prevalence, risk factors, and influence on quality of life", Head Neck, 37, pp.1733~1737 (2015)
- Yamaguchi A, "Trigger point therapy for myofascial pain in cancer patients(first report) : analysis results of special use-results surveillance by Neovitacain injection", Gan To Kagaku Ryoho, 38, pp.1659~1665 (2011)
- Simons DG, "Myofascial pain and dysfunction: the trigger point manual", pp.31~35 (1999), Lippincott Williams and Wilkins
- Seong JW, "Principle and insights into pain" (2015), Koonja Press
- Simons DG, "Muscle pain syndromes", J Man Med, 6, pp.3~23 (1991)
- Lang AM, "Botulinum toxin therapy for myofascial pain disorders", Curr Pain Headache Rep, 6, pp.355~360 (2002)
- Hasuo H, "Myofacial trigger points in advanced cancer patients", Indian J Palliat Care, 22, pp.80~84 (2016)
- "Cancer pain management guideline" (2010)[URL]
- Hubbard DR, "Chronic and recurrent muscle pain : pathophysiology and treatment, and review of pharmacologic studies", J Musculoskelet Pain, 4, pp.123~144 (1996)
- Gordon DB, "The use of"as-needed"range orders for opioid analgesics in the management of acute pain : a consensus statement of the American Society for Pain Management Nursing and the American Pain Society", Pain Manag Nurs, 5, pp.53~58 (2004)